Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 + 49 and TNF-α - 308 single nucleotide polymorphisms: A preliminary study

Transplant Immunology

Volumn 16, Issue 3-4, 2006, Pages 194-199

  Gendzekhadze, Ketevan ^a,b   Rivas Vetencourt, Pedro ^b   Montano, Ramón F ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

CTLA 4; Graft rejection; Kidney; SNP; TNF alpha; Transplantation

Indexed keywords

CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ADULT; ALLELE; ARTICLE; CADAVER KIDNEY; CHRONIC GRAFT REJECTION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; STEROID THERAPY;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; GENETIC MARKERS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33751308910     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.09.001     Document Type: Article

References (45)

1. Dai Z., and Lakkis F.G. The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection. Curr Opin Immunol 11 (1999) 504-508
2. Petranyi G.G. The complexity of immune and alloimmune response. Transplant Immunol 10 (2002) 91-100
3. Krummel M.F., and Allison J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183 (1996) 2533-2540
4. Keen L.J. The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transplant Immunol 10 (2002) 143-146
5. Auer J., Weber T., Berent R., Lassnig E., Lamm G., and Eber B. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am J Pharmacogenomics 3 (2003) 317-328
6. Ueda H., Howson J.M.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-511
7. Koss K., Satsangi J., Fanning G.C., Welsh K.I., and Jewell D.P. Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun 1 3 (2000) 185-190
8. Johnson G.C.L., Esposito L., Barratt B., Smith A.N., Heward J., DiGenova G., et al. Haplotype tagging for the identification of common disease genes. Nat Genet 29 (2001) 233-237
9. Wang X.B., Zhao X., Giscombe R., and Lefvert A.K. A CTLA-4 gene polymorphism at position - 318 in the promoter region affects the expression of protein. Genes Immun 3 4 (2002) 233-234
10. Maurer M., Loserth S., Kolb-Maurer A., Ponath A., Wiese S., Kruse N., et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon1 + 49) alters T-cell activation. Immunogenetics 54 (2002) 1-8
11. Hudson L.L., Rocca K., Song Y.W., and Pandey J.P. CTLA-4 gene polymorphism in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet 111 (2002) 452-455
12. Bouqbis L., Izaabel H., Akhayat O., Perez-Lezaun A., Calafell F., Bertranpetit J., et al. Association of the CTLA4 promoter region (- 1661G allele) with type 1 diabetes in the South Moroccan population. Genes Immun 4 2 (2003) 132-137
13. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor-alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94 (1997) 3195-3199
14. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
15. Pravica V., Perrey C., Stevens A., Lee J.H., and Hutchinson I.V. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61 (2000) 863-866
16. Awad M.R., El-Gamel A., Hasleton P., Turner D.M., Sinnott P.J., and Hutchinson I.V. Genotypic variation in the transforming growth factor-1 gene: association with transforming growth factor-1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66 (1998) 1014-1020
17. Huang D.R., Zhou Y.H., Xia S.Q., Liu L., Pirskanen R., and Lefvert A.K. Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease. J Neuroimmunol 94 (1999) 82-87
18. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1-8
19. Miller S., Dykes D., and Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 3 (1988) 1215
20. Kouki T., Sawai Y., Gardine C.A., Fisfalen M.E., Alegre M.L., and DeGroot L.J. CTLA-4 gene polymorphism at position 49 in Exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165 (2000) 6606-6611
21. Deichmann K., Heinzmann A., Bruggenolte E., Forster J., and Kuehr J. An MSE I RFLP in the human CTLA-4 promoter. Biochem Biophys Res Commun 225 (1996) 817-818
22. Kittles R.A., and Weiss K.M. Race, ancestry, and genes: implications for defining disease risk. Annu Rev Genomics Hum Genet 4 (2003) 33-67
23. Hoffmann S.C., Stanley E.M., Cox E.D., Craighead N., DiMercurio B.S., Koziol D.E., et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 72 (2001) 1444-1450
24. Cabrera M., Shaw M.A., Sharples C., Williams H., Castes M., Convit J., et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182 (1995) 1259-1264
25. Bidwell J., Keen L., Gallagher G., Kimberly R., Huizinga T., McDermott M.F., et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1 (1999) 3-19
26. Hutchinson I.V., Pravica V., Perrey C., and Sinnott P. Cytokine gene polymorphisms and relevance to forms of rejection. Transplant Proc 31 (1999) 734-736
27. Fernandez-Mestre M.T., Gendzekhadze K., Rivas-Vetencourt P., and Layrisse Z. TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 64 4 (2004) 469-472
28. Sankaran D., Asderakis A., Ashraf S., Roberts I.S.D., Short C.D., Dyer P.A., et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 56 (1999) 281-288
29. Slavcheva E., Albanis E., Jiao Q., Tran H., Bodian C., Knight R., et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection. Transplantation 72 5 (2001) 935-940
30. Marder B.A., Schroppel B., Lin M., Schiano T., Parekh R., Tomer Y., et al. The impact of costimulatory gene polymorphisms on clinical outcomes in liver transplantation. Am J Transplant 3 (2003) 424-431
31. De Reuver P., Pravica V., Hop W., Boor P., Metselaar H.J., Hutchinson I.V., et al. Recipient CTLA-4 + 49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation. Am J Transplant 3 (2003) 1587-1594
32. Dmitrienko S., Hoar D.I., Balshaw R., and Keown P.A. Immune response gene polymorphisms in renal transplant recipients. Transplantation 80 (2005) 1773-1782
33. Wisniewski A., Kusztal M., Magott-Procelewska M., et al. Possible association of cytotoxic T-lymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant. Transplant Proc 38 (2006) 56-58
34. Lamberts S.W., Huizenga A.T., de Lange P., de Jong F.H., and Koper J.W. Clinical aspects of glucocorticoid sensitivity. Steroids 61 (1996) 157-160
35. Ashwell J.D., Lu F.W.M., and Vacchio M.S. Glucocorticoids in T cell development and function. Annu Rev Immunol 18 (2000) 309-345
36. Van Laethem F., Baus E., Andris F., Urbain J., and Leo O. A novel aspect of the anti-inflammatory actions of glucocorticoids: inhibition of proximal steps of signaling cascades in lymphocytes. Cell Mol Life Sci 58 (2001) 1599-1606
37. Holopainen P.M., and Partanen J.A. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. J Immunol 167 (2001) 2457-2458
38. Hajeer A.J., and Hutchinson I.V. Influence of TNFα gene polymorphisms on TNFα production and disease. Hum Immunol 62 (2001) 1191-1199
39. Tinckam K., Rush D., Hutchinson I., Dembinsky I., Pravica V., Jeffrey J., et al. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation 79 7 (2005) 836-841
40. Alakulppi N.S., Kyllönen L.E., Jäntti V.T., Matinlauri I.H., Partanen J., Salmela K.T., et al. Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation. Transplantation 78 (2004) 1422-1428
41. Heidenreich S., Lang D., Tepel M., and Rahn K.H. Monocyte activation for enhanced tumour necrosis factor-alpha and interleukin-6 production during chronic renal allograft rejection. Transplant Immunol 2 1 (1994) 35-40
42. Sahoo S., Kang S., Supran S., Saloman R., Wolfe H., and Freeman R.B. Tumor necrosis factor genetic polymorphisms correlate with infections after renal transplantation. Transplantation 69 5 (2000) 880-884
43. Wilson A.G., de Vries N., Pociot F., di Giovine F.S., van der Putte L.B.A., and Duff G.W. An allelic polymorphism within the human tumor necrosis factor alfa promoter region is strongly associated wit HLA A1, B8, and DR3 alleles. J Exp Med 177 (1993) 557-560
44. Wilson A.G., Gordon C., diGiovine F.S., de Vries N., van de Putte L.B., Emery P., et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 24 (1994) 191-195
45. Makhatadze N.J., Franco M.T., and Layrisse Z. HLA class I and class II allele and haplotype distribution in the Venezuelan population. Hum Immunol 55 1 (1997) 53-58